Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk.

Breast Cancer Res Treat · 2021 · PMC8272709 · PMID 33891299

Europe PMC DOI

hedged sentence

0.1050

closest p · 2.1× alpha

0.1050

boldest claim

The sentences

did not reach statistical significancep = 0.105not close (p > 0.1)

In families with BRCA2 :c.7806-2A > G, the incidence of MBC cases was higher compared to families with other P/LPVs in BRCA2 ; however, the difference did not reach statistical significance (17.8% vs. 8.9%, p = 0.105).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.